<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Thirty-four patients received bone marrow transplants from unrelated donors </plain></SENT>
<SENT sid="1" pm="."><plain>Donors and recipients were phenotypically matched for 6 of 6 HLA-A, B, and DR antigens in 27 cases and at 5 of 6 antigens in 7 cases </plain></SENT>
<SENT sid="2" pm="."><plain>Twenty-three patients had <z:hpo ids='HP_0001909'>leukemia</z:hpo>, six had <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo>, and five had <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Twenty-four patients had durable engraftment </plain></SENT>
<SENT sid="4" pm="."><plain>Five died of <z:hpo ids='HP_0100806'>sepsis</z:hpo> prior to engraftment </plain></SENT>
<SENT sid="5" pm="."><plain>Five patients failed to engraft; 2 of these patients had autologous bone marrow recovery </plain></SENT>
<SENT sid="6" pm="."><plain>Seventeen patients developed grade greater than or equal to II <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> for an actuarial probability of 67 +/- 20% </plain></SENT>
<SENT sid="7" pm="."><plain>The severity of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> and its mortality appeared increased for recipients matched for 5 of 6 HLA-A, B, and DR antigens </plain></SENT>
<SENT sid="8" pm="."><plain>Of the 34 patients, 13 (38%) are alive; actuarial survival beyond 6 months is 44 +/- 17% </plain></SENT>
<SENT sid="9" pm="."><plain>None of the 25 <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> patients achieving engraftment have relapsed </plain></SENT>
<SENT sid="10" pm="."><plain>For <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> recipients of 6 of 6 HLA-matched grafts, actuarial survival at 6 months was 55 +/- 21% compared with 14 +/- 26% for recipients matched for 5 of 6 HLA loci (P = 0.19) </plain></SENT>
<SENT sid="11" pm="."><plain><z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">Infection</z:e> and <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> were the primary causes of <z:hpo ids='HP_0011420'>death</z:hpo> in the engrafted patients </plain></SENT>
<SENT sid="12" pm="."><plain>Survival for <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> patients was 20% </plain></SENT>
<SENT sid="13" pm="."><plain>Late <z:hpo ids='HP_0011420'>deaths</z:hpo> due to <z:hpo ids='HP_0002090'>pneumonia</z:hpo> and <z:hpo ids='HP_0011946'>bronchiolitis obliterans</z:hpo> occurred after one year in 2 patients </plain></SENT>
<SENT sid="14" pm="."><plain>Closely matched unrelated donor bone marrow transplants are associated with a higher incidence of graft failure and <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> than typically reported for transplants from HLA-identical siblings, but these preliminary data suggest a lower rate of relapse </plain></SENT>
</text></document>